Botanical species · safety record

Pluchea lanceolata

The EFSA Compendium of Botanicals holds 5 constituent measurements for Pluchea lanceolata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Pluchea lanceolata (DC.) C.B.Clarke

5Constituent measurements

0Safety records

4Cited sources

7Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 7 licensed products naming Pluchea lanceolata as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Herb top
Leaf

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Live plants	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Daidzein	Aerial part of plants	Solvent extraction	—	GC-MS	No resolvable identifier
Phenanthrenes	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Saponins	Roots and other underground parts	—	—	Phytochemical screening	No resolvable identifier
Tannins	Live plants	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Ramachandram, R., Ali, M. Isolation of monoterpenic ester, chromenone and steroidal lactone from Pluchea lanceolata roots. MEDICINAL CHEMISTRY, 1999, vol. 38, no. 1, p. 83-86.
Arya, D., Patni, V. Pharmacognostic profile and phytochemical investigation of Pluchea lanceolata Oliver & Hiern. In vivo and in vitro. International journal of pharmaceutical sciences review and research, 2013, vol. 22, no. 2, p. 157-161.
Gour, Kavi., Nathawat, Raghunandan Singh., Arya, Deepika., Patni, Vidya. GC-MS analysis and identification of daidzein by high performance thin layer chromatography (HPTLC) of Pluchea lanceolata - a bone healing plant of semi-arid land. Journal of pharmacy research, 2012, p. 257-260.
Sharma, Surendra Kr., Goyal, Naveen. Establishment of standardization parameters for root of Pluchea lanceolata (DC.) C. B. Clarke. Pharmacia sinica, 2012, p. 5-10.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature